Table 1. A summary of the previous literature focusing on adenoviral-mediated gene delivery to motor neurons via intramuscular injections.
Authors | Volume and Concentration of Adenovirus | Species/Strain | Age at Injection | Post-operational Time | Promoter | Gene of Interest | Injection Site | Transduction Site |
---|---|---|---|---|---|---|---|---|
Ghadge et al.21 | 5–70 μl of 0.5–1.0 × 1010 pfu/ml, | SJL/J Mice | 4–6 weeks old | 1–10 days | CAG | LacZ | Tibialis Ant., Tongue | Lumbar ventral horn, Hypoglossal Nucleus |
Petrof et al.62 | 200 μl of 3×1012 pfu/ml | MDX and C57Bl6 mice | 5–8 weeks old | 1 week | RSV, CMV | Luc, LacZ | 2 or 3 separate injections in the hemidiaphragm | Only muscle was analysed |
Giménez y Ribotta et al.69 | 4 μl of 1.2–4 × 107 pfu/ml | SD Rats | Post natal day 1 | 7 days | RSV | LacZ, BDNF, GDNF | Nasolabial or lower lip muscles | Facial Nuclei |
Haase et al.23 | 100 μl of 1 × 109 pfu/ml | PMN Mice | 3–5 days old | Up to 88 days | RSV | Luc, NT-3 | Gastrocnemius, Triceps Brachii, Dorsal Trunk muscles | Muscles and L2-L4 Spinal Cord Segments |
Baumgartner and Shine22 | 10 μl of 1.9 × 108 pfu/ml | SD Rats | Newborn | 7 days | RSV | β-Gal, BDNF, CNTF, GDNF | Facial muscles of the cheek, lower lip and whisker pad | Facial nucleus |
Baumgartner and Shine26 | 10 μl of 1.9 × 108 pfu/ml 10 μl of 5 × 108 pfu/ml | SD Rats | 1 day old | 7 days, 21 days or 42 days | RSV | NT-3, CNTF, BDNF, GDNF, β-Gal, | Three different sites in the Gastrocnemius, Flexor Longus Digitorum and Tibialis Anterior muscles | Lumbar ventral horn |
Baumgartner and Shine27 | 15 μl of 3 × 108 pfu/ml | SD Rats | 1 day old | At 2 days facial nerve was severed. 4 or 20 weeks | RSV | GDNF, β-Gal, | Nasiolabialis, Frontalis and Auricularis Anterior muscles | Facial nucleus |
Haase et al.74 | 1 × 109 pfu/ml | PMN Mice | 3–5 days old | 40–88 days | RSV | NT-3 | Gastrocnemius, Triceps Brachii, Dorsal Trunk muscles | Lumbar ventral horn |
Glatzel et al.24 | 3 μl of 2.5 × 107 pfu/ml | C57BL/6 Mice | Unknown | 7–21 Days | CMV, RSV | LacZ | Tibialis Cranialis | Not observed |
Soudais et al.70 | 3–5 × 1012 pfu | Swiss OF1 Mice | 4 days old | 24 Days | CMV | GFP | Gastrocnemius | Sacral Dorsolumbar Rachis Ventral Horn |
Yamashita et al.45 | 5–10 μl of 0.5–1 × 1011 pfu/ml | SOD1-G93A and B6SJL Mice | 1–35 weeks old | 2–5 days, 1, 2 and 4 weeks | CAG | LacZ, Bcl-2, Cre | Middle or right side of the tongue | Hypoglossal Nucleus |
Acsadi et al.46 | 5 μl of 5 × 109 pfu/ml | SOD1-G93A Mice | 5–7 days old | 2, 3 and 4 months | CMV | GDNF, eGFP, LacZ | Tibialis anterior, Gastrocnemius, Quadriceps and Paraspinal muscles | Lumbar ventral horn |
Martinov et al.28 | 2–8 μl of 1.0 × 1012 pfu/ml | NMRI Mice, Wistar Rats | Adult | 6–41 days | CMV | eGFP, Luc | Soleus, extensor digitorum longus | Lumbar ventral horn |
Millecamps et al.71 | 108 pfu/μl | C57BL/6, SOD1-G93A mice | 45 or 130 days old | 8 days | PGK, RSV | Luc, β-Gal, | 4 sites in the tongue, 2 sites in Triceps Brachii and 2 sites in Gastrocnemius | Hypoglossal Nucleus |
Yamashita et al.72 | 5–10 μl of 0.3×1011 pfu/ml | SOD1-G93A and B6SJL mice | 10 weeks | 25 weeks | CAG | Bcl-2, Cre | Middle or right side of the tongue | Hypoglossal Nucleus |
Tsai et al.73 | 10 μl of 6.0 × 108 pfu/ml, | FVB/NJ mice | 12 day old | 4–9 days | PGK | eGFP | Gastrocnemius | Lumbar ventral horn |
Nakajima et al.31 | 100 μl of 5.0 × 108 pfu/ml | Wistar Rats | 12–14 weeks | 3 days-4 weeks | CAG | LacZ | Middle section of the superficial layer of the Sternomastoid muscle | Medulla-C8 |
Nakajima et al.32 | 100 μl of 5.0 × 108 pfu/ml | SD Rats | 8–10 weeks | 3 days-4 weeks | CAG | BDNF, LacZ | Middle section of the superficial layer of the Sternomastoid muscle | Medulla-C8 |
Uchida et al.33 | 2.5 μl of 5 × 1010 pfu/ml | Twy mice | 16 weeks old | 1–4 weeks | CAG | NT-3, LacZ | Middle belly of the superficial layer of the Sternomastoid muscle | Medulla- C7 |
Nakajima et al.29 | 100 μl of 5.0 × 109 pfu/ml | SD Rats | 8–10 weeks | 1–6 weeks | CAG | BDNF, LacZ | Middle belly of the superficial layer of the Sternomastoid muscle | Medulla-C7 |
Uchida et al.25 | 25 μl of 1.0 × 108 pfu/ml | Twy mice | 18 week old | 4 weeks | CAG | BDNF, LacZ | Middle belly of the superficial layer of the Sternomastoid muscle | Medulla- C3 |
This table highlights the diversity in adenoviral-mediated gene delivery methods utilised in the last 20 years. β-Gal: beta-galactosidase; BDNF: brain-derived neurotrophic factor; CAG: CMV-enhancer chicken β–actin hybrid promoter; CMV: cytomegalovirus immediately early promoter; CNTF: cilliary-derived neurotrophic factor; GDNF: glial-derived neurotrophic factor; Luc: luciferase; LacZ: lactose operon Z; NGF: nerve growth factor; NT-3: neurotrophin-3; RSV: Rous-sarcoma virus long terminal repeat promoter.